v3.25.2
Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 30, 2023   29,337,920      
Balance at beginning of period at Dec. 30, 2023 $ (457,366) $ 293 $ 2,676 $ (459,994) $ (341)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 28,747     28,747  
Shares issued under stock plans (in shares)   42,918      
Shares issued under stock plans 708 $ 1 707    
Tax payments for restricted stock upon vesting (in shares)   (10,860)      
Tax payments for restricted stock upon vesting (3,717)     (3,717)  
Stock-based compensation expense, net of forfeitures 3,812   3,812    
Dividends declared on common stock and equivalents (6,539)   (6,277) (262)  
Currency translation adjustment (24)       (24)
Balance at end of period (in shares) at Mar. 30, 2024   29,369,978      
Balance at end of period at Mar. 30, 2024 (434,379) $ 294 918 (435,226) (365)
Balance at beginning of period (in shares) at Dec. 30, 2023   29,337,920      
Balance at beginning of period at Dec. 30, 2023 (457,366) $ 293 2,676 (459,994) (341)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 56,232        
Currency translation adjustment (36)        
Balance at end of period (in shares) at Jun. 29, 2024   29,304,401      
Balance at end of period at Jun. 29, 2024 (437,541) $ 293 1,869 (439,326) (377)
Balance at beginning of period (in shares) at Mar. 30, 2024   29,369,978      
Balance at beginning of period at Mar. 30, 2024 (434,379) $ 294 918 (435,226) (365)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 27,485     27,485  
Shares issued under stock plans (in shares)   11,323      
Shares issued under stock plans 546   546    
Purchases of common stock (in shares)   (75,862)      
Purchases of common stock (29,220) $ (1) (4,304) (24,915)  
Tax payments for restricted stock upon vesting (in shares)   (1,038)      
Tax payments for restricted stock upon vesting (401)     (401)  
Stock-based compensation expense, net of forfeitures 4,926   4,926    
Dividends declared on common stock and equivalents (6,486)   (217) (6,269)  
Currency translation adjustment (12)       (12)
Balance at end of period (in shares) at Jun. 29, 2024   29,304,401      
Balance at end of period at Jun. 29, 2024 $ (437,541) $ 293 1,869 (439,326) (377)
Balance at beginning of period (in shares) at Dec. 28, 2024 28,662,614 28,662,614      
Balance at beginning of period at Dec. 28, 2024 $ (675,586) $ 287 1,568 (676,940) (501)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 92,265     92,265  
Shares issued under stock plans (in shares)   109,964      
Shares issued under stock plans 0 $ 1 (1)    
Purchases of common stock (in shares)   (830,012)      
Purchases of common stock (120,769) $ (8) (5,179) (115,582)  
Tax payments for restricted stock upon vesting (in shares)   (39,678)      
Tax payments for restricted stock upon vesting (11,597) $ (1)   (11,596)  
Stock-based compensation expense, net of forfeitures 5,312   5,312    
Dividends declared on common stock and equivalents (7,866)   (409) (7,457)  
Currency translation adjustment 3,259       3,259
Balance at end of period (in shares) at Mar. 29, 2025   27,902,888      
Balance at end of period at Mar. 29, 2025 $ (714,982) $ 279 1,291 (719,310) 2,758
Balance at beginning of period (in shares) at Dec. 28, 2024 28,662,614 28,662,614      
Balance at beginning of period at Dec. 28, 2024 $ (675,586) $ 287 1,568 (676,940) (501)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 119,028        
Currency translation adjustment $ 7,990        
Balance at end of period (in shares) at Jun. 28, 2025 27,923,753 27,923,753      
Balance at end of period at Jun. 28, 2025 $ (685,998) $ 279 3,791 (697,557) 7,489
Balance at beginning of period (in shares) at Mar. 29, 2025   27,902,888      
Balance at beginning of period at Mar. 29, 2025 (714,982) $ 279 1,291 (719,310) 2,758
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 26,763     26,763  
Shares issued under stock plans (in shares)   28,298      
Shares issued under stock plans 855   855    
Tax payments for restricted stock upon vesting (in shares)   (7,433)      
Tax payments for restricted stock upon vesting (2,002)     (2,002)  
Stock-based compensation expense, net of forfeitures 6,217   6,217    
Dividends declared on common stock and equivalents (7,580)   (4,572) (3,008)  
Currency translation adjustment $ 4,731       4,731
Balance at end of period (in shares) at Jun. 28, 2025 27,923,753 27,923,753      
Balance at end of period at Jun. 28, 2025 $ (685,998) $ 279 $ 3,791 $ (697,557) $ 7,489